Author:
Ferrándiz M. L.,Foster S. J.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Toxicology,Pharmacology,Immunology
Reference27 articles.
1. S. J. Hopkins and A. Meager,Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon. Clin. Exp. Immunol.73, 88–92 (1988).
2. D. E. Yocum, L. Esparza, S. Dubry, J. B. Benjamin, R. Volz and P. Scuderi,Characteristics of tumour necrosis factor production in rheumatoid arthritis. Cellular Immunol.122, 131–145 (1989).
3. F. M. Brennan, D. Chantry, A. Jackson, R. Maini and M. Feldmann,Inhibitory effect of TNF-alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. The Lancet. July29, 244–247 (1989).
4. J. Le and J. Vilcek,Tumour necrosis factor and interleukin-1: cytokines with multiple overlapping biological activities. Lab. Invest.56, 234–248 (1987).
5. Y. Fong, K. J. Tracey, L. L. Moldawer, D. G. Hesse, K. B. Manogue, J. S. Kenney, A. T. Lee, G. C. Kuo, A. C. Allison, S. F. Lowry and A. Cerami,Antibodies to cachectin/tumour necrosis factor reduce interleukin-1 beta and interleukin-6 appearance during lethal bacteremia. J. Exp. Med.170, 1627–1633 (1989).
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献